Beta-blockers are generally considered first-line treatment for patients with the obstructive phenotype; disopyramide helps relieve symptoms for patients who have failed first-line therapy with beta-blockers, verapamil, or diltiazem Patients who continue to experience symptoms related to significant outflow tract gradients (≥ 50 mm Hg) despite medical therapy are candidates for invasive treatment.